Cybin to present at the 2024 bloom burton & co. healthcare investor conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will present at the 2024 bloom burton & co. healthcare investor conference, taking place april 16-17, 2024 in toronto, ontario. mr. drysdale's prese.
CYBN Ratings Summary
CYBN Quant Ranking